Consumer Study Coordinator (Part-Time - 2nd shift) - Richmond, Virginia
Celerion
Summary
Celerion is currently seeking a part-time Consumer Study Coordinator at our Richmond, VA location. Our Richmond location focuses on consumer opinion studies related to nicotine and tobacco products.
Job description
This position is Part-time and will work around 20 hours per week. We are looking for candidates with the flexibility to work between the hours of 4:30pm-9:30pm, Monday–Friday based on business needs.
As a Consumer Study Coordinator, you will be responsible for the preparation and maintenance of all stages of participant activities including screening, training, and evaluations. Duties include entering and updating study information into computer systems, collecting and organizing panelist’s paperwork and documentation, and developing positive participant communications and relationships.
Requirements
We are seeking candidates with great customer service, administrative skills and the ability to work a part-time flexible schedule. Consumer/market research experience is preferred. Ability to work in required work environment, including but not limited to exposure to second hand smoke from combustible cigarettes and vapors from electronic cigarettes on a daily basis.
According to the Code of Virginia 18.2-371.2B, employees must be 21 years of age to work around tobacco products.
Requirements
- Great customer service skills
- Administrative skills
- Ability to work a part-time flexible schedule
- Consumer/market research experience preferred
- Ability to work in environment with exposure to second hand smoke and e-cigarette vapors
- Must be at least 21 years of age
Company overview
Celerion is a global leader in early clinical research and a premier clinical research organization (CRO) specializing in early-phase drug development. Founded in 2010 with roots dating back to 1969, the company operates with over 50 years of experience in conducting clinical trials. Celerion focuses on Phase 1 studies, including first-in-human dose escalation, drug-drug interactions, cardiac safety, bioequivalence, metabolism, and pharmacokinetics in patient populations. The company's name derives from the Latin 'celeritas,' meaning swiftness and speed, reflecting its commitment to accelerating drug development timelines. With more than 1,000 full-time scientific and medical personnel and over 650 clinical beds across global facilities in North America, Europe, and Asia, Celerion provides comprehensive services including clinical pharmacology studies, bioanalytical services, data management, biostatistics, and regulatory support. The company has conducted over 6,000 studies and works with pharmaceutical and biotechnology clients to enable faster, informed decisions in drug development, helping bring new medicines to market more efficiently.